NASDAQ$BTTC

Black Titan Corp · Q4 2014 earnings

Q4 2014 earnings · · Investor relations

Headline financials

Total Revenue

$912K

Previous: $911K+0.1%
EPS (adj)

-$198.18

Previous: -$2.33-8417.6%
Net Income

-$473K

Previous: -$209K-126.3%
Operating Income

-$1.25M

Previous: -$642K-95.2%
Gross Profit

-$683K

Previous: -$18K-3694.4%
R&D Expense

$1.6M

Previous: $929K+71.7%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$912K

Q4 2014+0.1%vs Q4 2013
Beat estimate in 6 of 6 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro